An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

NCT00644332 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Angina

Interventions

DRUG: Ranolazine

Sponsor

Gilead Sciences